// App-Quantinova.ai

4064 : Botezomib Containing Regimens Provide a Rapid Hematological and Cardiac Response in Patients with AL Amyloidosis

Researchers

Presenter

  • Donna Reece

Principal Investigators

  • Suzanne Trudel

  • Christine I. Chen

  • Rodger E. Tiedemann

  • Vishal Kukreti

Medical Centers

  • McLaughlin Centre for Molecular Medicine, Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • AL Amyloidosis

Biomarkers

  • Troponin I

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bortezomib

  • Melphalan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved